Platform & AI
Oncology Interoperability Software
HL7, FHIR, X12 and APIs that link an oncology practice with hospitals, labs, payers and data partners.
Oncology Interoperability Software moves data between a medical oncology practice and the systems around it: hospitals, labs, payers, data warehouses and partner apps. It reads and sends HL7 v2 messages, FHIR resources over REST, X12 claim and remittance files and JSON APIs, and checks each message before it reaches the record.


Interoperability in a Oncology Practice
A medical oncology practice trades data with far more than its own EHR. Hospitals send notice when a patient on treatment is admitted or seen in the ER. Labs send blood counts before each dose. Payers send eligibility replies, claim status and remittances. Patients send symptom reports from home. Oncology interoperability puts each of these on a standard path. HL7 v2 ADT and SIU messages carry patient and visit events, and DFT messages carry charges, including chemotherapy doses. FHIR REST feeds carry clinical summaries and ePRO data. X12 files carry eligibility, claims, status and ERAs through the clearinghouse. APIs and webhooks let partner tools read schedules or post payments. A format checker fixes common syntax slips and rejects bad messages, and every new link is tested in a sandbox first. The link to the practice's own EHR is covered under oncology EHR integration.
Why Is Interoperability Different in Oncology?
Oncology care spreads across many places. A patient may get chemotherapy in the clinic, scans at a hospital, labs at an outside lab and urgent care in an ER. For the Enhancing Oncology Model, those outside events matter, because hospital use counts toward the episode. Interoperability is how the practice learns about them in time to act, rather than from a claim long after.
Payer data is changing too. Under CMS's Interoperability and Prior Authorization rule, impacted payers must offer a Prior Authorization API starting in 2027. The rule leaves drugs out, which matters in oncology, where most approvals are for drugs. CMS has proposed a separate rule for drugs. A practice needs links that work with today's X12 and portal paths and can grow as payers add new ones.
There is also a duty to share. Under federal information blocking rules, health care providers are actors and must not interfere with the access, exchange or use of electronic health information unless an exception applies. A practice that keeps data in closed silos risks more than slow work. Clean, standard HL7 and FHIR links make it easier to share data when a patient or partner asks.
What Oncology Interoperability Software Handles
- Hospital ADT event notices
- Hospitals must make a reasonable effort to send admission, discharge and transfer notices to practitioners the patient names as primarily responsible for their care. When a hospital sends these notices over HL7, FHIR or API, whichever the system supports, staff work them from a general task queue and note the admission on the patient's record. (CMS: Admission, Discharge, and Transfer Patient Event Notification Conditions of Participation (42 CFR 482.24(d)))
- Payer Prior Authorization API (CMS-0057-F)
- Impacted payers, such as Medicare Advantage and Medicaid plans, must build a Prior Authorization API starting January 1, 2027, but drugs are excluded. Drug approvals stay on each payer's current paths, such as its portal. (CMS Fact Sheet: CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F))
- Drug prior authorization proposal (CMS-0062-P)
- CMS has proposed extending many of the electronic prior authorization rules to drugs for the same payers. At the time of writing it is a proposed rule, so drug approval paths are tracked payer by payer. (CMS: Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P))
- HL7 v2 messages (ADT, SIU, DFT)
- HL7 v2 is the message standard most clinical systems still use. ADT and SIU messages carry patient and scheduling events, and DFT messages carry financial transactions such as chemotherapy doses, which post to the charge record. (HL7 International: HL7 Version 2 Product Suite)
- X12 835 remittances
- Medicare contractors send ERAs in the X12 835 version 5010 format, with standard CARC and RARC codes for each adjustment. These files arrive through the clearinghouse and post to the lines they pay. (CMS: Health Care Payment and Remittance Advice (X12 835 version 5010))
- Information blocking rules
- Federal rules treat health care providers as actors who must not interfere with the access, exchange or use of electronic health information without an exception. Standard APIs and FHIR feeds give the practice a clean way to share data when asked. (ASTP/ONC HealthIT.gov: Information Blocking)
How Does Oncology Interoperability Software Work?
1. Map the partners
List each outside system: hospitals, labs, payers, the clearinghouse, ePRO tools and the data warehouse. Pick the standard each one uses, such as HL7 v2, FHIR, X12 or a JSON API.
2. Build and test in a sandbox
Each link is set up and tested with sample messages in the sandbox. Test panels show how each field maps before live data flows.
3. Check every message
Incoming messages pass a format check that fixes common syntax slips and rejects bad ones. Rejected messages go to a queue with the reason.
4. Match to the patient
Each message is matched to the right patient and visit. Hospital admission notices that arrive over a supported channel go to a general task queue for the care team, which feeds oncology value-based care work.
5. Watch the links
Each link is logged, with encrypted transport end to end. Failed or late feeds are flagged, so staff know when a hospital or lab feed has stopped.
Oncology Interoperability Software vs. Generic Software
| Area | Generic approach | Unlimited Systems |
|---|---|---|
| Hospital events | Learned from a patient call or a claim. | Hospital notices worked from a task queue. |
| Message formats | A custom interface for each partner. | HL7 v2, FHIR, X12 and JSON APIs on one layer. |
| Bad messages | Errors found when a record looks wrong. | Format checks reject or fix messages on arrival. |
| New links | Built and tested in production. | Tested in a sandbox with test panels first. |
| Payer paths | Portals only, worked by hand. | X12 and portal paths, with payer API rules tracked by payer. |
Who Uses It in a Oncology Practice
- Nurse navigator: Hospital admission and ER notices, where the hospital sends them, worked from a task queue so outreach can start the same day.
- IT lead: One layer for HL7 v2, FHIR, X12 and APIs, with sandbox testing and message logs, built on the oncology platform design.
- Practice administrator: Fewer phone calls to hospitals and labs for data that can arrive on its own.
Oncology Interoperability Software FAQs
For a medical oncology practice, interoperability means data moves on standard paths between the practice and hospitals, labs, payers, patients and partner tools. HL7 v2 carries patient, scheduling and charge events, FHIR carries clinical and symptom data, and X12 carries claims and remittances. Each link is tested, checked and logged.
Hospitals must make a reasonable effort to send admission, discharge and transfer notices to practitioners the patient names as primarily responsible for their care, and an oncologist can be that practitioner. When a hospital sends them over HL7, FHIR or API, whichever the system supports, staff work them from a general task queue, so the care team sees the admission and can follow up.
The CMS Interoperability and Prior Authorization rule excludes drugs. Impacted payers must offer a Prior Authorization API for items and services starting in 2027, but drug approvals fall outside it. CMS has proposed a separate rule to extend many of these rules to drugs. Until then, drug approvals stay on each payer's current paths.
Each incoming message passes a format check. Common syntax slips are fixed, and messages that can't be read are rejected and sent to a queue with the reason. Staff can then ask the sender to resend. Bad data is stopped at the door instead of showing up later as a wrong record.
Partner tools can use APIs with JSON data to query schedules, read claim data and post patient payments through webhooks. Developers work in a sandbox with test panels before going live. Access is logged, and data moves over encrypted links, so each partner sees only what it is set up to use.
Federal information blocking rules treat health care providers as actors who must not interfere with the access, exchange or use of electronic health information without an exception. Standard FHIR feeds and APIs give the practice a clean way to share data when a patient, provider or partner asks, and each exchange is logged.
Related Oncology Software
Platform & AI
In the revenue cycle
Interoperability for related specialties
Sources
- CMS: Admission, Discharge, and Transfer Patient Event Notification Conditions of Participation (42 CFR 482.24(d))
- CMS Fact Sheet: CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F)
- CMS: Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P)
- HL7 International: HL7 Version 2 Product Suite
- CMS: Health Care Payment and Remittance Advice (X12 835 version 5010)
- ASTP/ONC HealthIT.gov: Information Blocking
GET STARTED
See Unlimited Systems in Action
Whether you're actively evaluating new technology or simply preparing for your next vendor renewal, Unlimited Systems can help you understand where your current workflows may be creating avoidable revenue risk.


